NASDAQ:OGI - OrganiGram Stock Price, News, & Analysis

$6.47
+0.37 (+6.07 %)
(As of 07/16/2019 02:24 PM ET)
Today's Range
$6.08
Now: $6.47
$6.47
50-Day Range N/A
52-Week Range
$2.97
Now: $6.47
$8.44
Volume33,056 shs
Average Volume992,175 shs
Market Capitalization$1.01 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
CUSIPN/A
CIKN/A
Phone844-644-4726

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees615
Market Cap$1.01 billion
Next Earnings Date10/21/2019 (Estimated)
OptionableNot Optionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

OrganiGram (NASDAQ:OGI) Frequently Asked Questions

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) posted its earnings results on Monday, July, 15th. The company reported ($0.07) EPS for the quarter, missing the Zacks' consensus estimate of $0.02 by $0.09. The company had revenue of $30.36 million for the quarter, compared to analysts' expectations of $30.81 million. The company's quarterly revenue was up 782.6% compared to the same quarter last year. View OrganiGram's Earnings History.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release their next quarterly earnings announcement on Monday, October 21st 2019. View Earnings Estimates for OrganiGram.

What is the consensus analysts' recommendation for OrganiGram?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OrganiGram.

Has OrganiGram been receiving favorable news coverage?

Media headlines about OGI stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. OrganiGram earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for OrganiGram.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB), Aphria (APHA), CannTrust (CNTTF), Aurora Cannabis (ACBFF), Tilray (TLRY), HEXO (HEXO) and Aphria (APHQF).

Who are OrganiGram's key executives?

OrganiGram's management team includes the folowing people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Exane Derivatives (0.03%), Rothschild Investment Corp IL (0.02%), Ingalls & Snyder LLC (0.01%), Davis Rea LTD. (0.01%) and Truvestments Capital LLC (0.00%).

Which institutional investors are buying OrganiGram stock?

OGI stock was bought by a variety of institutional investors in the last quarter, including Exane Derivatives, Rothschild Investment Corp IL, Ingalls & Snyder LLC, Davis Rea LTD. and Truvestments Capital LLC.

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $6.47.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $1.01 billion. OrganiGram employs 615 workers across the globe.View Additional Information About OrganiGram.

What is OrganiGram's official website?

The official website for OrganiGram is http://www.organigram.ca/.

How can I contact OrganiGram?

OrganiGram's mailing address is 35A ENGLISH DR., MONCTON A3, E1E 3X3. The company can be reached via phone at 844-644-4726.


MarketBeat Community Rating for OrganiGram (NASDAQ OGI)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  158
MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel